Article Versions Notes

Lee H, Ryu HS, Park HC, Yu JI, Yoo GS, Choi C, Nam H, Lee JJB, Do I-G, Han D, et al. Dual Oxidase 2 (DUOX2) as a Proteomic Biomarker for Predicting Treatment Response to Chemoradiation Therapy for Locally Advanced Rectal Cancer: Using High-Throughput Proteomic Analysis and Machine Learning Algorithm. International Journal of Molecular Sciences. 2022; 23(21):12923. https://doi.org/10.3390/ijms232112923

Lee, Hyebin, Han Suk Ryu, Hee Chul Park, Jeong Il Yu, Gyu Sang Yoo, Changhoon Choi, Heerim Nam, Jason Joon Bock Lee, In-Gu Do, Dohyun Han, and et al. 2022. "Dual Oxidase 2 (DUOX2) as a Proteomic Biomarker for Predicting Treatment Response to Chemoradiation Therapy for Locally Advanced Rectal Cancer: Using High-Throughput Proteomic Analysis and Machine Learning Algorithm" International Journal of Molecular Sciences 23, no. 21: 12923. https://doi.org/10.3390/ijms232112923

Lee, H., Ryu, H. S., Park, H. C., Yu, J. I., Yoo, G. S., Choi, C., Nam, H., Lee, J. J. B., Do, I.-G., Han, D., & Ha, S. Y. (2022). Dual Oxidase 2 (DUOX2) as a Proteomic Biomarker for Predicting Treatment Response to Chemoradiation Therapy for Locally Advanced Rectal Cancer: Using High-Throughput Proteomic Analysis and Machine Learning Algorithm. International Journal of Molecular Sciences, 23(21), 12923. https://doi.org/10.3390/ijms232112923